Table 2 Treatment and clinical outcomes of the 58 analyzed patients with CSCI

Intubation before admission, n (%)

3 (5.2)

2 (15.4)

1 (2.2)

8.0 (0.66–96.4)

0.1230

Initial ICU admission, n (%)

3 (5.2)

2 (15.4)

1 (2.2)

8.0 (0.66–96.4)

0.1230

CAS in acute stage, n (%)

19 (32.7)

10 (76.9)

9 (20.0)

13.33 (3.02–58.7)

0.0003*

Atelectasis in acute stage, n (%)

15 (25.9)

8 (61.6)

7 (15.6)

8.68 (2.12–34.4)

0.0022*

Pneumonia in acute stage, n (%)

2 (3.4)

1 (7.7)

1 (2.2)

3.66 (0.21–63.03)

0.4010

Steroid administration, n (%)

31 (53.4)

8 (61.6)

23 (51.1)

1.53 (0.43–5.40)

0.5461

Halo-Vest immobilization, n (%)

9 (15.5)

4 (30.8)

5 (11.1)

3.55 (0.79–15.94)

0.1025

Cervical spine surgery, n (%)

31 (53.4)

9 (69.2)

22 (48.9)

2.35 (0.63–8.76)

0.2248

Time from injury to surgery, median [IQR], days

5 [2–9]

3 [2.5–5]

6 [1–10]

0.2362

Tracheostomy, n (%)

8 (13.8)

7 (53.9)

1 (2.2)

51.33 (5.34–493.04)

< 0.0001*

Emergency medical center stay, median [IQR], days

21 [15–34]

36 [28–44]

18 [12–28]

0.0009*

Hospital stay, median [IQR], days

24 [15–54]

57 [35–62]

21 [13–36]

0.0004*

> 28 days, n (%)

24 (41.3)

11 (84.6)

13 (28.8)

13.53 (2.62–69.71)

0.0008*

Discharged with dysphasia, n (%)

11 (18.9)

7 (53.9)

4 (8.9)

11.95 (2.67–53.4)

0.0012*

Discharged with ventilator dependence, n (%)

2 (3.4)

2 (15.4)

0

N/A

0.0489*

In-hospital death, n (%)

1 (1.7)

1 (7.7)

0

N/A

0.2241